Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights
What Is the Projected Growth Rate of the Electrocompetent Cells Market Through 2029?
The electrocompetent cells market size has grown strongly in recent years. It will grow from $1.43 billion in 2024 to $1.57 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing demand for recombinant protein production, a rise in academic and government research funding, the expansion of molecular biology studies, the adoption of gene cloning techniques, and the availability of high-efficiency E. coli strains.
The electrocompetent cells market size is expected to see strong growth in the next few years. It will grow to $2.29 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing application in synthetic biology, rising demand for CRISPR-based gene editing, expansion of personalized medicine research, emergence of automation in transformation protocols, and increasing investments by biotech startups. Major trends in the forecast period include CRISPR-compatible electrocompetent cells, high-efficiency transformation strains, chemically defined growth media integration, automation in cell preparation, and cold-chain optimized packaging for stability.
Claim your free report sample now:
Which Drivers Are Positively Impacting the Electrocompetent Cells Market?
The rising demand for genetic engineering is expected to propel the growth of the electrocompetent cells market going forward. Genetic engineering involves intentionally changing an organism's genetic material to modify its traits or behavior. The rise in genetic engineering is driven by the need for higher agricultural productivity, allowing the creation of crops with increased yields and pest resistance, minimizing chemical reliance. The growing need for genetic engineering fuels the demand for electrocompetent cells, which are crucial for efficient DNA transformation. As genetic modifications expand across research, healthcare, and agriculture, the need for premium electrocompetent cells is rising. For instance, in April 2025, according to the Economic Research Service, a US-based government agency, in 2024, genetically engineered, insect-resistant seeds were used on 90 percent of cotton acres in the U.S. Therefore, the rising demand for genetic engineering is driving the growth of the electrocompetent cells market.
Which Are the Leading Segments in the Electrocompetent Cells Market by Revenue?
The electrocompetent cells market covered in this report is segmented –
1) By Product Type: Bacterial Electrocompetent Cells, Yeast Electrocompetent Cells, Plant Electrocompetent Cells, Mammalian Electrocompetent Cells
2) By Technology: Electroporation Technology, Chemical Transformation Technology, Other Technologies
3) By Packaging Format: Tubes, Plates, Custom Formats
4) By Application: Gene Cloning, Protein Expression, Transfection Studies, Gene Editing, Therapeutic Applications, Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Other End-Users
Subsegments:
1) By Bacterial Electrocompetent Cells: E. coli Electrocompetent Cells, Salmonella Electrocompetent Cells, Clostridium Electrocompetent Cells, Bacillus Electrocompetent Cells
2) By Yeast Electrocompetent Cells: Saccharomyces Cerevisiae Electrocompetent Cells, Pichia Pastoris Electrocompetent Cells, Schizosaccharomyces Pombe Electrocompetent Cells
3) By Plant Electrocompetent Cells: Arabidopsis Thaliana Electrocompetent Cells, Nicotiana Benthamiana Electrocompetent Cells, Maize Electrocompetent Cells
4) By Mammalian Electrocompetent Cells: HEK293 Electrocompetent Cells, Chinese Hamster Ovary (CHO) Electrocompetent Cells, NIH 3T3 Electrocompetent Cells
What Are the Key Trends Shaping the Electrocompetent Cells Market?
Major companies operating in the electrocompetent cells market are focusing on developing advanced solutions, such as automated cell processing technology, to improve scalability in genetic engineering workflows. Automated cell processing technology involves software-driven systems that manage the handling, cultivation, modification, and preservation of cells with minimal manual input. This approach improves operational efficiency, standardization, and scalability in areas such as cell therapy, regenerative medicine, and biomanufacturing. For instance, in March 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled the Gibco CTS Xenon electroporation system, introducing a fully customizable, large-volume electroporation platform designed to enable rapid, efficient, and non-viral gene modification for cell therapy development and manufacturing. This system allows developers to easily scale from clinical development to commercial manufacturing by offering programmable electroporation conditions, high cell viability (up to 80%), and efficient gene knockout (up to 90%) for hard-to-transfect cell types, all within a closed, sterile, and flexible workflow.
Who Are the Top Companies Contributing to the Electrocompetent Cells Market Expansion?
Major companies operating in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Biosciences, Bio-Rad Laboratories Inc., Takara Bio Inc., Promega Corporation, New England Biolabs, OriGene Technologies, MaxCyte, LGC Biosearch Technologies, IBA GmbH, Zymo Research, Creative Biolabs, Inovio Pharmaceuticals Inc., Canvax, Yeastern Biotech, ZellBio GmbH, Scarab Genomics LLC, Intact Genomics.
Get the full electrocompetent cells market report here:
How Are Market Trends Differentiating Across Key Regions in the Electrocompetent Cells Market?
North America was the largest region in the electrocompetent cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocompetent cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment